Vanguard Global Advisers’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
Vanguard Global Advisers's STIM Position: Q3 2026 in Review
Vanguard Global Advisers held its Neuronetics (STIM) position steady in Q3 2026 at 16,453 shares worth $38.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3149.
Vanguard Global Advisers first reported a position in STIM in Q1 2026 and has held it in 3 quarters since. 95 funds tracked by Wall St. Rank hold STIM as of Q3 2026.
- Vanguard Global Advisers held 16,453 shares of Neuronetics worth $38.5K as of Q3 2026.
- Vanguard Global Advisers left its Neuronetics share count unchanged in Q3 2026.
- Neuronetics made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3149 holding.
- Vanguard Global Advisers first reported a position in Neuronetics in Q1 2026 and has held it in 3 quarters since.
- 95 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.